Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. (Q45125272)

9 December 2017

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. (English)

1 reference

9 December 2017

0 references

Carlos Cepeda

1

1 reference

9 December 2017

Amaal J Starling

2

1 reference

9 December 2017

Nanping Wu

3

1 reference

9 December 2017

Oanh K Nguyen

4

1 reference

9 December 2017

Besim Uzgil

5

1 reference

9 December 2017

Takahiro Soda

6

1 reference

9 December 2017

Veronique M André

7

1 reference

9 December 2017

Marjorie A Ariano

8

1 reference

9 December 2017

Michael S Levine

9

1 reference

9 December 2017

1 December 2004

1 reference

Journal of Neuroscience Research

9 December 2017

1 reference

9 December 2017

78

1 reference

9 December 2017

855-867

1 reference

9 December 2017

6

1 reference

Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.

9 December 2017

1 reference

Striatal neurochemical changes in transgenic models of Huntington's disease

21 January 2018

1 reference

Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals

21 January 2018

1 reference

Dopamine excites fast-spiking interneurons in the striatum

21 January 2018

1 reference

BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression

21 January 2018

1 reference

NMDA receptor function in mouse models of Huntington disease

21 January 2018

1 reference

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

21 January 2018

1 reference

Neocortical damage alters synaptic responses of neostriatal neurons in vitro.

21 January 2018

1 reference

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study

21 January 2018

1 reference

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

21 January 2018

1 reference

Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice.

21 January 2018

1 reference

Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia

21 January 2018

1 reference

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

21 January 2018

1 reference

Organization of GABA receptor alpha-subunit clustering in the developing rat neocortex and hippocampus

21 January 2018

1 reference

Parvalbumin is expressed in glutamatergic and GABAergic corticostriatal pathway in mice

21 January 2018

1 reference

Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability.

21 January 2018

1 reference

Inhibitory control of neostriatal projection neurons by GABAergic interneurons

21 January 2018

1 reference

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect

21 January 2018

1 reference

Alterations in 3H-GABA binding in Huntington's chorea

21 January 2018

1 reference

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

GABA is toxic for mouse striatal neurones through a transporter-mediated process

21 January 2018

1 reference

Which GABAA-receptor subtypes really occur in the brain?

21 January 2018

1 reference

Mouse models of Huntington's disease

21 January 2018

1 reference

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

21 January 2018

1 reference

Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity

21 January 2018

1 reference

Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice

21 January 2018

1 reference

Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease

21 January 2018

1 reference

When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function

21 January 2018

1 reference

Can lesions of GPe correct HD deficits?

21 January 2018

1 reference

Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease

21 January 2018

1 reference

Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation

21 January 2018

1 reference

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

21 January 2018

1 reference

Huntington's disease: the challenge for cell biologists

21 January 2018

1 reference

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.20344

1 reference

9 December 2017

1 reference